A Comparison for Time for Drug Administration Guidance and Patient’s Pharmacy Stay between Anti-influenza Drugs in Insurance Pharmacies

DOI Web Site

Bibliographic Information

Other Title
  • 保険薬局における抗インフルエンザ薬の服薬指導時間および薬局内滞在時間の評価
  • ホケン ヤッキョク ニ オケル コウインフルエンザヤク ノ フクヤク シドウ ジカン オヨビ ヤッキョク ナイ タイザイ ジカン ノ ヒョウカ

Search this article

Abstract

<p>Anti-influenza drugs are dispensed in both oral and inhalation formulations in health insurance pharmacies. The drug administration guidance time of oral formulations may be shorter than that of inhaled formulations, but no studies have reported the time for drug administration guidance of two formulations of anti-influenza drugs in pharmacies. Therefore, we measured the time for drug administration guidance and the patient’s pharmacy stay using time stamp data in pharmacies for patients prescribed oral (oseltamivir and/or baloxavir marboxil) and inhaled (zanamivir and/or laninamivir) anti-influenza drugs in the 2018–2019 season. The mean time for drug administration instruction for anti-influenza drugs was 3.13 min (n=44,080) and 4.68 min (n=19,710) for oral and inhaled agents, respectively, suggesting that it was about 1.5 times longer in inhaled agents than oral agents. The mean time of pharmacy stay for patients prescribed oral and inhaled agents of anti-influenza was 14.61 min (n=49,572) and 14.98 min (n=22,937), respectively, with a small time difference. Further studies are needed to elucidate the benefit from shorter contact time during oral treatment.</p>

Journal

Keywords

Details 詳細情報について

Report a problem

Back to top